spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  HALO90 

 HSMN NewsFeed - 17 May 2012
Covidien Introduces HALO90 ULTRA Ablation Catheter for Treatment of Barrett’s Esophagus
Devices Gastroenterology
 HSMN NewsFeed - 21 Nov 2011
BARRX Medical, Inc. Announces Definitive Agreement to be Acquired by Covidien
Devices Mergers & Acquisitions
 HSMN NewsFeed - 21 Nov 2011
Covidien Announces Definitive Agreement to Acquire BÂRRX Medical, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 10 Mar 2011
Practice Guidelines Confirm Utility of Endoscopic Radiofrequency Ablation (RFA) for the Treatment of Barrett's Esophagus
Devices Gastroenterology
 HSMN NewsFeed - 7 Sep 2010
BARRX Medical Signs Distribution Agreement With Medico's Hirata for Exclusive Distribution of the HALO Radiofrequency Ablation System in Japan
Devices Gastroenterology Distribution
 HSMN NewsFeed - 3 Mar 2010
FDA Provides 510k Clearance for BARRX Medical's HALO90 Ablation Catheter for the Treatment of Radiation Proctitis and Gastric Antral Vascular Ectasia (GAVE)
Devices Gastroenterology FDA
 HSMN NewsFeed - 21 Jul 2008
Precancerous Esophagus Disease Eliminated in 98.4% of Patients Treated With HALO Ablation System
Devices Gastroenterology
 HSMN NewsFeed - 19 May 2008
Presentation of Landmark Clinical Trial Evaluating Endoscopic Treatment for Pre-cancerous Condition of Esophagus
Devices Gastroenterology
 HSMN NewsFeed - 15 May 2008
New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barrett's Esophagus
Devices Gastroenterology
 HSMN NewsFeed - 20 May 2007
Presentation of Long-term Results for Treating Barrett's Esophagus with HALO Ablation System
Devices Gastroenterology
 HSMN NewsFeed - 15 May 2007
Genetic Abnormalities Associated With Esophageal Cancer Eliminated After Treatment With HALO Ablation System
Devices Gastroenterology
 HSMN NewsFeed - 5 Feb 2007
Study Reports 70% of Barrett's Esophagus Patients Cured at One-Year Follow-Up in Multi-Center Study
Devices
 HSMN NewsFeed - 20 Jul 2006
BARRX Medical, Inc. Secures $27.8 Million Series C Venture Funding
Devices Venture Capital
 HSMN NewsFeed - 23 May 2006
Nine Clinical Studies Evaluating Safety and Efficacy of HALO360 and HALO90 Systems to Treat Barrett's Esophagus Presented at Digestive Disease Week
Devices Gastroenterology
 HSMN NewsFeed - 26 Apr 2006
BARRX Medical, Inc. Announces FDA Clearance of the HALO90 System for the Treatment of Barrett's Esophagus
Devices FDA
 HSMN NewsFeed - 26 Apr 2006
Investigators To Present Positive Clinical Trial Results Underscoring the Efficacy of BARRX Medical's Ablation Systems for Barrett's Esophagus
Devices
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.